Hazards from the Health Food Store—Part II

Mon, 4/21/08 - 3:44pm
0 Comments
3237 reads

Citation:

Pages 34 - 40

Authors:

Asha M. Thomas, MD, FACE, and Steven R. Gambert, MD, AGSF, MACP

Release Date: April 15, 2008
Expiration Date: April 15, 2009

TARGET AUDIENCE
Internists, family practitioners, geriatricians, cardiologists, and others who care for older patients.

MEDIUM USED & METHOD OF PARTICIPATION
Read the article, complete the evaluation and post-test, and return both to: NACCME via fax at (610) 560-0502. You will receive your certificate in 6-8 weeks. If you would like to print your certificate immediately, go to http://cme.naccme.com, register as a NACCME user, and access the activity test and evaluation online.

SUCCESSFUL COMPLETION
Successful completion entails participants obtaining a score of at least 70% on the post-test. A certificate of completion will be mailed to the address listed on your post-test/evaluation form within 6-8 weeks of receipt of the documents.

ACCREDITATION
MD/DO:
This activity is sponsored by the North American Center for Continuing Medical Education (NACCME). NACCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been planned and produced in accordance with the ACCME Essential Areas and Policies.

SPONSOR
This activity is sponsored by The North American Center for Continuing Medical Education.

DISCLOSURES
All those with control over the content of continuing education programs sponsored by NACCME are expected to disclose whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). It is not assumed that these relationships will have an adverse impact on presentations; they are simply noted here to fully inform participants.

Drs. Thomas and Gambert have disclosed that they have no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of their article.

Reviewer: Dr. Christmas has disclosed no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this article.

Editor: M. Edwards has disclosed no significant financial relationship.

All NACCME employees involved in the planning and editing of this educational activity have disclosed that they have no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of this educational activity.

References:

1. Durga J, Verhoef P, Anteunis LJ, et al. Effects of folic acid supplementation on hearing in older adults: A randomized, controlled trial. Ann Intern Med 2007;146(1):1-9.
2. Levy J, Hanners SE, Stevens W. Dietary fish oil decreases body fat by enhancing thermogenesis and by inhibiting white preadipocyte dysfunction. Presented at: Endocrine Society Annual Meeting; June 2-5, 2007; Toronto, Canada.
3. Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med 2006;354(6):557-566.
4. Cheema P, El-Mefty O, Jazieh AR. Intraoperative haemorrhage associated with the use of extract of Saw Palmetto herb: A case report and review of literature. J Intern Med 2001;250(2):167-169.
5. Stern RG, Mohs RC, Davidson M, et al. A longitudinal study of Alzheimer’s disease: Measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 1994;151(3):390-396.
6. Schneider LS, DeKosky ST, Farlow MR, et al. A randomized, double-blind, placebo-controlled trial of two doses of Ginkgo biloba extract in dementia of the Alzheimer’s type. Curr Alzheimer Res 2005;2(5):541-551.
7. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998;55(11):1409-1415.
8. Arase Y, Ikeda K, Murashima N, et al. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 1997;79(8):1494-1500.
9. Heikens J, Fliers E, Endert E, et al. Liquorice-induced hypertension--a new understanding of an old disease: Case report and brief review. Neth J Med 1995;47(5):230-234.
10. Melchart D, Walther E, Linde K, et al. Echinacea root extracts for the prevention of upper respiratory tract infections: A double-blind, placebo-controlled randomized trial. Arch Fam Med 1998;7(6):541-545.
11. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;(343):1-19.
12. Pellati F, Benvenuti S, Magro L, et al. Analysis of phenolic compounds and radical scavenging activity of Echinacea spp. J Pharm Biomed Anal 2004;35(2):289-301.
13. Muller-Jakic B, Breu W, Probstle A, et al. In vitro inhibition of cyclooxygenase and 5-lipoxygenase by alkamides from Echinacea and Achillea species. Planta Med 1994;60(1):37-40.
14. Luettig B, Steinmuller C, Gifford GE, et al. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst 1989;81(9):669-675.
15. Di Carlo G, Nuzzo I, Capasso R, et al. Modulation of apoptosis in mice treated with Echinacea and St. John’s wort. Pharmacol Res 2003;48(3):273-277.
16. Echinacea. In: Jellin JM, Gregory P, Batz, F, et al, eds. Natural Medicines Comprehensive Database. Stockton, CA; Therapeutic Research Faculty; 2004.
17. Taylor JA, Weber W, Standish L, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: A randomized controlled trial. JAMA 2003;290(21):2824-2830.
18. Mullins RJ. Echinacea-associated anaphylaxis. Med J Aust 1998;168(4):170-171.
19. Soon SL, Crawford RI. Recurrent erythema nodosum associated with Echinacea herbal therapy. J Am Acad Dermatol 2001;44(2):298-299.
20. Logan JL, Ahmed J. Critical hypokalemic renal tubular acidosis due to Sjogren’s syndrome: Association with the purported immune stimulant echinacea. Clin Rheumatol 2003;22(2):158-159.
21. Brinker F, ed. Herb Contraindications and Drug Interactions. Sandy, OR: ND Eclectic Medical Publications; 1998.
22. Newall C, Anderson LA, Phillipson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: Pharmaceutical Press; 1996.
23. St. John’s wort: Hypericum perforatum. In: Upton, R, ed. American Herbal Pharmacopoeia and Therapeutic Compendium. Santa Cruz, CA: American Herbal Pharmacopoeia; 1997:3-32.
24. Bennett DA Jr, Phun L, Polk JF, et al. Neuropharmacology of St. John’s wort (Hypericum). Ann Pharmacother 1998;32(11):1201-1208.
25. Hypericum Depression Trial Study Group. Effect of Hypericum perforatum (St John’s wort) in major depressive disorder: A randomized controlled trial. JAMA 2002;287(14):1807-1814.
26. Knuppel L, Linde K. Adverse effects of St. John’s wort: A systematic review. J Clin Psychiatry 2004;65(11):1470-1479.
27. Gulick RM, McAuliffe V, Holden-Wiltse J, et al. Phase I studies of hypericin, the active compound in St. John’s wort, as an antiretroviral agent in HIV-infected adults. AIDS Clinical Trials Group Protocols 150 and 258. Ann Intern Med 1999;130(6):510-514.
28. Mills E, Montori VM, Wu P, et al. Interaction of St John’s wort with conventional drugs: Systematic review of clinical trials. BMJ 2004;329(7456):27-30.
29. Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John’s wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003;290(11):1500-1504.
30. Wong AH, Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998;55(11):1033-1044.
31. Lantz MS, Buchalter E, Giambanco V. St. John’s wort and antidepressant drug interactions in the elderly. J Geriatr Psychiatry Neurol 1999;12(1):7-10.
32. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001;286(2):208-216.
33. Keenan NL, Mark S, Fugh-Berman A. Severity of menopausal symptoms and use of both conventional and complementary/alternative therapies. Menopause 2003;10(6):507-515.
34. Umland EM, Cauffield JK, Kirk JK, Thomason TE. Phytoestrogens as therapeutic alternatives to traditional hormone replacement in postmenopausal women. Pharmacotherapy 2000;20(8):981-990.
35. Duker EM, Kopanski L, Jarry H, Wuttke W. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 1991;57(5):420-444.